In 2019, ACGT launched a pilot Biotechnology Investment Program. The organization is seeking opportunities to fund the right science at the right time with a current 2019/20 focus on glioblastoma and pancreatic cancers.
In tandem with our academic grants, we will fund innovative programs that have the potential to
significantly advance cell and gene therapy for cancer. All returns on investment are applied to continuing ACGT
For further information please contact:
Barbara Lavery, Chief Program Officer